Nephrology Flashcards
AKI etiology after arterial cath
- CIN
2. atheroembolic emboli (if persistent 5 days after) + Eos
Renal injury after bowel prep
phosphate nephropathy - check phosphate level
avoid fleet enema
> 50 yo
CKD
DM
Abdominal compartment syndrome
IAP >20 w/ AKI (N 6-7)
Treatment of Abdominal compartment syndrome
decompressive laparotomy
Minimal change dz clues
- sudden onset
- Hodgkins dz + NSAIDS
FSGS
AA patient with nephrotic syndrome
HIV
obesity
membranous nephropathy
malignancy associated (25% is from a secondary cause)
Ddx for nephrotic syndrome a/w AKI
- MCG w ATN or
AIN - membranous w. b/l renal vein thrombosis
- amyloid w cast nephropathy
definitive dx of nephrotic syndrome
renal bx
Role of prophylactic AC in nephrotic syndrome
none
Role of bicarb in CKD when bicarb is <22
slows progression of CKD (sodium bicarbonate or sodium citrate)
Consequences of untreated chronic metabolic acidosis
muscle loss
bone loss
Treatment for primary Minimal change
glucocorticoids
ace/arb
diuretics
cholesterol lowering meds if total >200
Monoclonal gammopathy of renal significance
MGUS + renal insufficiency –> renal bx
Treatment of IgA nephropath
ACE/ARB
Role of any immunosuppression in IgA
controversial - never will be the answer
Causes of calcium oxalate stones in malabsorption/diarrhea
- urne citrate is an inhibitor of crystallization that is reduced in metabolic acidosis
- enteric calcium binds to poorly absorbed fat allowing oxalate to be absorbed and excreted in the urine
clues to dysproteinema related kidney disease
older, hypercalcemia, anemia, evidence of proximal tubular dysfunction (hypoK, hypophos, metabolic acidosis,
diagnosis of diabetic nephropathy
clinical. doesn’t need bx if 8 years of dm + nephrotic
Constellation of symptoms a/w MM
Old, hypercalcemia, anemia, NAGMA, AKI
Treatment of ethylene glycol
fomepizole, fluids, HD
lab findings of ethylene glycol
NAGMA, osmlol gap
osmol gap
measured - calculated >10
MOA of renal damage of ethylene glycol
calcium oxalate crystal deposition
AutoAB in 75% of primary cases of membranous glomerulopatny
PLA2R
Treatment of nephrogenic DI
thiazides
Tolvaptaan
vasopressin antagonist use for SIAD
heparin does what to K
hyperK+ (2/2 hypoaldosteronism)
> 50% of RPGN etiology
ANCA associated vasculitis
SE of chronic Tylenol use in patients with CKD, liver dz or poor nutrition
pyroglutamic acidosis (AGMA)
Pyroglutamic acidosis
too much Tylenol depleting glutathione
Acid-base disturbance in patients with short gut
D lactic acidosis
Acid base disturbance with salicylate
respiratory alkalosis
or RA with AGMA
Hematuria
> 3 rbc/hpf
AUA risk factors for lower urinary tract malignancy
> 35 w irritative voiding symptoms, smoking, aniline dyes or cyclophosphamide
risk factors to vanc nephrotoxicity
CKD, troughs >15, and concomitant use of loop diuretics
Correction of acute hyponatremia
can be rapid. 2-3mmol immediately
Correction rate of chronic hyponatremia
<10 in 24 hours.
imaging for new diagnosis of fibromuscular dysplasia
one time head to pelvic imaging to look for aneurysms.
Serum Cr elevation of more than 30% after initiation of ACE
look for fibromuscular dysplasia
When to test for primary aldosternonism
- resistant HTN, adrenal mass
- spontaneous hypokalemia
- diuretic induced hypokalemia
Dialysis and statins
Recommends against, in patients with ESRD, unless they have residual function of kidneys
Gold standard for nephrolithiasis
Non contrast, helical CT
Management of primary membranous nephropathy
PLA2R highly specific
- high rates of remission in 6-12 months. statin (if applicable) plus ace/arb and monitor. if things change or persistent nephrotic protein start immunosuppressants
- After alternating months of steroids + alkylating agents (can use cyclosporine if can’t use alkylating ages)
Distal type 1 RTA
hyperchlorema, hypoKalemia 2/2 inability to excrete acid
type 4 RTA
distal hyperkalemic (2/2 aldosterone def or resistance), NAGMA
type 2 (prox)
issue with bicarb reclaiming
Needed in the Dx of HELLP
MAHA (peripheral smear and bili level)
B2 micro globulin associated amyloid pts
seen in dialysis for at least 5 years, present with shoulder pain, carpal tunnel
Triad of hyperaldosteronism
metabolic alkalosis
hypokalemia
resistant HTN
How to evaluate metabolic alkalosis
urine Cl
saline responsive metabolic alkalosis lab
urine cl <15
management of hypermagnesemia
saline
lasix
IV calcium
electrolyte issues 2/2 hypomag
hypoK
hypoCa (increased PTH increase)
Primary bug of post infectious GN
s. aureas (more so co exists, rather than post strep - 7 day lag)
Gout ppt element that causes a chronic tubulointerstitial disease
Lead - ca
Acidosis associated with crohns or short gut
D lactic acidosis
AGMA, non osmol
AGMA, osmol gap
ethylene glycol, methanol
OP meds for HTN and conception
labetolol, nifedipine, methyldopa
Immunosuppresants ok in pregnancy
AZA, tacrolimus, cyclosporine
urine dipstick detects what kind of protein
albumin (not light chains)
- useful if you have a high protein/cr ration but small protein on urine to detect things other than albuminuria
GFR of when to start evaluating for kidney transplant
GFR <30
TIPS indication
- variceal hemorrhage
- refractory ascites
Risk: increased HE, renal injury 2/2 contrast
Etiology of hyperNa with urine ism 300-600
urea osmotic diuresis or glucose diuresis
HTN med for difficult to control blood pressure w CKD
add a Loop (esp with cKd, cirrhosis, heart failure)
thiazides have less use as a diuretic with GFR <30
4 variables to predict CKD progression
- age
- sex
- GFR
- albumin - cr ratio
presentation of renal amyloid
nephrotic
bland ua
inflammatory conditions
TX: toci (IL-6)
NSAID nephropathy
- AIN
- Membranous (pyuria, abc casts, proteinuria)
- MC
Concern in ESRD pt with macroscopic hematuria or flank pain
RCC!
they have increased risk
When to initiate HD in CKD patients
don’t need to start until symptomatic (uremic, fluid overload, acidosis)
Nephrotic syndromes
- minimal change
- membranous
- membranoproliferative (only has low complements -rest wnl)
- FSGS
Membranous nephropathy
Solid Cancer!! age appropriate screening
FSGS
think AA!
Obesity!
HIV
Membranous nephropathy
Caucasian! higher risk of clots (renal vein thrombosis - LDH) carcinoma SLE, RA Tx: ACEI, immunomodulation
membranoprolif
hep C (low complements)